NYSEMKT: CITRCitrotech Inc Stock
$6.48-0.19 (-2.85%)
Updated Jun 5, 2026
CITR Price
$6.48
Fair Value Price
N/A
Market Cap
$144.88M
52 Week Low
$6.00
52 Week High
$10.37
P/E
-3.03x
P/B
16.68x
P/S
92.51x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.76M
Earnings
-$32.14M
Gross Margin
19%
Operating Margin
-1,498.07%
Profit Margin
-1,829.6%
Debt to Equity
0.41
Operating Cash Flow
-$7M
Beta
0.44
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CITR's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Chemical
Industry Rating
A
CITR
Ranked#50 of 51
Ranked#50 of 51
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $5.43 | A | |
| $40.81 | A | |
| $12.85 | A |
Be the first to know about important CITR news, forecast changes, insider trades & much more!
CITR News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CITR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CITR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CITR is poor value based on its book value relative to its share price (16.68x), compared to the US Specialty Chemicals industry average (3.64x)
P/B vs Industry Valuation
CITR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CITR due diligence checks available for Premium users.
Valuation
CITR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.03x
Industry
7.05x
Market
12.7x
CITR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
16.68x
Industry
3.64x
CITR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CITR's financial health
Profit margin
Revenue
$344.9k
Net Income
-$6.2M
Profit Margin
-1,800.6%
CITR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CITR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.2M
Liabilities
$3.6M
Debt to equity
0.41
CITR's short-term assets ($5.63M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CITR's short-term assets ($5.63M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CITR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.1M
Investing
-$10.7k
Financing
$88.4k
CITR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CITR vs Specialty Chemical Stocks
Citrotech Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.